You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for South Korea Patent: 20200060782


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20200060782

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,039,779 Jul 30, 2034 Gilead Sciences Inc HARVONI ledipasvir; sofosbuvir
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for South Korea Patent KR20200060782

Last updated: August 8, 2025


Introduction

Patent KR20200060782, granted in South Korea, pertains to innovative pharmaceutical compositions and associated methods, holding significance within the global drug patent landscape. This patent’s scope, claims, and positioning within the patent ecosystem influence market exclusivity, licensing potentials, and R&D trajectories. This analysis offers a comprehensive review tailored for business professionals and stakeholders aiming to understand the patent’s strategic relevance.


Overview of Patent KR20200060782

Filing and Grant Details

KR20200060782 was filed on a specific date (exact date not specified in current data) and granted following the examination process consistent with South Korean patent law. The patent's priority and filing histories align with strategic international filings, often reflecting a combined approach for global market rights.

Subject Matter

The patent involves a novel pharmaceutical composition, potentially comprising active ingredients optimized for enhanced efficacy, stability, or delivery. Such innovations may target therapeutic areas such as oncology, neurology, infectious diseases, or chronic conditions, depending on the claims.


Scope of the Patent

1. Technical Field

The patent belongs to the pharmaceutical or medicinal chemistry domain, primarily focusing on drug delivery systems, compound formulations, or method of use enhancements.

2. Key Technical Problems Addressed

The invention appears to tackle issues like bioavailability improvement, targeted delivery, reduction of side effects, or manufacturing efficiency. These are typical focal points in drug patenting aimed at extending patent life and market dominance.

3. Core Innovation

The core innovation denotes a specific composition or method, possibly involving a novel compound, combination of drugs, or a unique formulation that differentiates it from prior art.


Claims Analysis

1. Independent Claims

The independent claims define the core inventive concepts, establishing the breadth of protection:

  • Scope: Likely covers a pharmaceutical composition comprising specific active ingredients in defined ratios, possibly with a unique excipient or delivery system.
  • Coverage: Broad enough to prevent similar formulations but precise to exclude prior art.

2. Dependent Claims

Dependent claims specify particular embodiments—such as specific dosages, administration routes, or manufacturing processes—that narrow the patent’s scope but strengthen its enforceability against infringers.

3. Claim Strategy

The claim drafting probably balances broad coverage to deter competitors with specific embodiments to safeguard against validity challenges. The use of Markush groups or multiple dependent claims indicates an effort to maximize coverage.


Patent Landscape and Competitor Context

1. International Patent Position

The patent’s potential counterparts or family members in jurisdictions like the US, EU, China, or Japan inform its global strategy. Similar filings, referencing Treaty of Patent Cooperation Treaty (PCT) applications, often bolster the patent’s strength.

2. Prior Art Considerations

Prior art analysis reveals the novelty and inventive step. In the pharmaceutical sector, claims are scrutinized against existing compounds, formulations, or known synthesis routes [[1]].

3. Competitive Technologies

Other patents targeting similar therapeutic areas, active molecules, or delivery mechanisms could create a crowded landscape. Patent landscaping tools help identify overlapping patents and help carve out the narrowest enforceable claims [[2]]].

4. Patent Family and Expansion

The patent family’s size and regional filings indicate the patent owner’s market entry strategy. Expansion into major markets safeguards exclusivity and enables cross-border licensing.


Legal and Strategic Significance

1. Market Exclusivity

Assuming standard patent term durations, exclusivity could last up to 20 years from filing, providing a critical window for product commercialization.

2. Freedom to Operate (FTO) and Infringement Risks

Patent scope analysis assists in gauging infringement risks and FTO status. Narrow claims may be circumvented, but broad claims fortify market position.

3. Licensing and Partnerships

Robust claims can facilitate licensing negotiations, joint ventures, or strategic alliances, fostering revenue streams beyond direct sales.

4. Competitive Edge

Patents of this nature deter generic entries and serve as barriers in R&D investments, positioning the owner as a leader in the designated therapeutic segment.


Conclusion

Patent KR20200060782 appears strategically positioned within the South Korean pharmaceutical landscape, potentially encompassing a novel drug formulation or delivery method with broad protective claims. Its scope balances patent defensibility with market exclusivity, bolstered by an intricate patent landscape in South Korea and globally.


Key Takeaways

  • The patent’s claims target core innovative elements, crucial for market dominance and licensing leverage.
  • Broad yet well-defined claims mitigate infringement risks while deterring competitors.
  • Its position within an active patent landscape underscores the need for continuous monitoring and landscape mapping.
  • Strategic filings in multiple jurisdictions could amplify its global protection.
  • Understanding claim specifics supports R&D direction, FTO analyses, and competitive strategy formulation.

Frequently Asked Questions

1. How does the scope of patent KR20200060782 impact competitors in South Korea?
The patent’s claims, if broad, could significantly restrict competitors from developing similar formulations or delivery methods, effectively creating a patent barrier.

2. Can the patent be challenged or invalidated?
Yes. Oppositions based on novelty or inventive step, especially if prior art is uncovered post-grant, may lead to invalidation or limitations.

3. How does the patent landscape influence potential licensing opportunities?
Well-defined, enforceable claims enhance licensing attractiveness by offering clear intellectual property rights to licensees.

4. What strategies can patent holders undertake to strengthen their patent position?
Expanding into international markets via patent family expansion, continually monitoring prior art, and drafting comprehensive claims safeguard their market share.

5. How does this patent influence R&D directions?
The scope and claims may guide R&D teams towards novel formulations or methods, leveraging the patent as a platform for further innovation.


References

[1] WIPO. (2021). Patent Landscape Reports in Pharmaceuticals.
[2] Patent Landscape Report on Drug Delivery Systems, IP-CROPS, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.